- Home
- GNLX vs DTF Comparison
GNLX vs DTF Comparison
Compare GNLX & DTF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GNLX
- DTF
- Stock Information
- Founded
- GNLX 2001
- DTF 1991
- Country
- GNLX United States
- DTF United States
- Employees
- GNLX N/A
- DTF N/A
- Industry
- GNLX Biotechnology: Pharmaceutical Preparations
- DTF Investment Managers
- Sector
- GNLX Health Care
- DTF Finance
- Exchange
- GNLX Nasdaq
- DTF Nasdaq
- Market Cap
- GNLX 85.0M
- DTF 79.4M
- IPO Year
- GNLX 2023
- DTF N/A
- Fundamental
- Price
- GNLX $3.13
- DTF $11.20
- Analyst Decision
- GNLX Strong Buy
- DTF
- Analyst Count
- GNLX 4
- DTF 0
- Target Price
- GNLX $18.25
- DTF N/A
- AVG Volume (30 Days)
- GNLX 80.9K
- DTF 21.1K
- Earning Date
- GNLX 11-14-2024
- DTF 01-01-0001
- Dividend Yield
- GNLX N/A
- DTF 3.64%
- EPS Growth
- GNLX N/A
- DTF N/A
- EPS
- GNLX N/A
- DTF 0.44
- Revenue
- GNLX $8,000.00
- DTF N/A
- Revenue This Year
- GNLX N/A
- DTF N/A
- Revenue Next Year
- GNLX N/A
- DTF N/A
- P/E Ratio
- GNLX N/A
- DTF $24.34
- Revenue Growth
- GNLX N/A
- DTF N/A
- 52 Week Low
- GNLX $1.60
- DTF $10.29
- 52 Week High
- GNLX $12.12
- DTF $11.19
- Technical
- Relative Strength Index (RSI)
- GNLX 68.05
- DTF 48.98
- Support Level
- GNLX $2.25
- DTF $11.13
- Resistance Level
- GNLX $2.57
- DTF $11.45
- Average True Range (ATR)
- GNLX 0.25
- DTF 0.06
- MACD
- GNLX 0.06
- DTF 0.01
- Stochastic Oscillator
- GNLX 71.31
- DTF 20.59
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
About DTF DTF Tax-Free Income 2028 Term Fund Inc.
DTF Tax-Free Income 2028 Term Fund Inc is a diversified closed-end management investment company. The Fund's investment objective is current income exempt from regular federal income tax consistent with the preservation of capital. It seeks to achieve its investment objective by investing primarily in a diversified portfolio of investment-grade tax-exempt obligations.